Laurence A. Turka

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jennifer Kamocsay, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurence A. Turka:

Company Role Class Num Shares Value Price $ Report Date Ownership
Rubius Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 25,875 31 Jan 2023 Direct
Rubius Therapeutics, Inc. Chief Scientific Officer Common Stock 18,391 31 Jan 2023 Direct

Insider Reports Filed by Laurence A. Turka

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923008873-turka-laurence-a-2023-01-29 Rubius Therapeutics, Inc. 29 Jan 2023 5 -$622 4 Chief Scientific Officer 31 Jan 2023, 20:50
/report/000117911022000693-turka-laurence-a-2022-01-29 Rubius Therapeutics, Inc. 29 Jan 2022 5 -$16,544 4 Chief Scientific Officer 01 Feb 2022, 20:18